More recently, heterozygous de novo dominant DNM2 mutations affecting the PH domain have also been identified in a more severe CNM phenotype without any early peripheral nerve involvement and characterised by neonatal onset but gradual improvement over time [81]. Here, DNM2 is linked to centronuclear myopathy.